Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, February 6, 2025 to discuss Medexus's results for its third fiscal quarter ended ...

Lazard Ltd (NYSE:LAZ) reported its fourth-quarter earnings for 2024, surpassing expectations with an earnings per share (EPS) of $0.78, compared to the forecast of $0.63. Revenue also exceeded ...